Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Use of Xtampza ER to Overcome Difficulties in Swallowing Opioid Pills

Trial Profile

Use of Xtampza ER to Overcome Difficulties in Swallowing Opioid Pills

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 19 Jun 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Oxycodone (Primary)
  • Indications Pain
  • Focus Therapeutic Use

Most Recent Events

  • 18 May 2020 Status changed from completed to discontinued.(Reason the study was stopped: Study halted permanently and will not resume; participants are no longer being examined or receiving intervention.
  • 11 Nov 2019 Status changed from recruiting to completed.
  • 20 Jul 2018 New trial record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top